U.S. federal trademark · Serial No. 88191876
CBD isolate sold in crystal form as an integral ingredient in anti-inflammatory, anti-seizure, anti-nausea, and anti-psychotic ointments, containing CBD with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.